Synthesis method of amino acid substituted N-sulfonyl amidine derivative
Patent Information
- Application Number
- CN202411163540.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-23
- Publication Date
- 2024-11-29
AI Technical Summary
The existing synthesis process of N-sulfonylamidine compounds has complex operation, harsh reaction conditions and safety risks. In particular, the use of metal catalysts and oxidants may lead to metal contamination and explosion risks, limiting their application in actual production.
By using a metal-free and oxidant-free synthetic method, the reaction was carried out by reacting amino acid-substituted sulfonamide, bromodifluoroacetate and triethylamine in an organic solvent, and reacting at 60±3°C for 6±0.5 hours, followed by concentration and purification. The amino acid-substituted N-sulfonylamidine derivative was isolated by flash column chromatography on silica gel.
It realizes the efficient synthesis of various amino acids in substituted N-sulfonylamidine derivatives under mild conditions, avoids metal pollution and explosion risks, is stable and easy to control, and reduces production costs. This method does not require water and oxygen-free treatment, and is simple to operate. , safe and friendly.
Smart Images

Figure CN119039187A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of organic synthesis, and particularly relates to a method for synthesizing an amino acid-substituted N-sulfonyl amidine derivative. Background Art
[0002] N-sulfonyl amidines have a wide range of applications in organic synthesis. They are not only key building blocks for the synthesis of nitrogen-containing heterocyclic compounds, but can also act as ligands to chelate transition metals for catalysis. In addition, sulfonyl amidine compounds have been found to have important anti-cancer, anti-proliferation and absorption inhibition drug activities, and can be used in the synthesis of drug lead compounds.
[0003] Amino acid compounds have good biocompatibility, are easy to penetrate into tissues, and have the characteristics of good targeting and high safety. In addition, different types of amino acids have significant antibacterial activity and broad-spectrum antibacterial properties, and are widely used in the design and structural modification of antibacterial drugs.
[0004] Based on the functional effects of N-sulfonyl amidine and amino acid, it is expected that the amino acid-substituted N-sulfonyl amidine derivatives composed of the two types of molecular fragments have better biological activity, and obtain lead or candidate compounds with research prospects. N-sulfonyl amidine can be synthesized by transition metal catalysis (J.Am.Chem.Soc.2005,127,2038; J.Org.Chem.2015,80,2448; Chem.Commun.2018,54,8222; J.Org.Chem.2020,85,2092; Curr.Org.Synth.2022,19,797); (J.Am.Chem.Soc.2008,130,14048; Org.Lett.2010,12,897; Chem.Commun.2009,7372; Org.Lett.2011,13,6152; J.Org.Chem.2022,87,11644); through visible light-mediated catalytic synthesis (Org.Lett.2019,21,2804; RSC Adv.2021,11,18966; Adv.Synth.Catal.2019,361,3656); through electrochemical synthesis (Chem.Commun.2020,56,5010; Adv.Synth.Catal.2023,365,96; Org.Lett.2024,26,193) and other routes. However, although the above-mentioned approaches have greatly broadened the synthesis methods of N-sulfonyl amidines, most of these methods require the use of potentially explosive azides, stoichiometric or catalytic amounts of transition metal catalysts, or require harsh reaction conditions. In addition, these methods are rarely reported for the synthesis of amino acid-substituted N-sulfonyl amidine derivatives.
[0005] In the existing N-sulfonyl amidine compound synthesis process, some technologies use catalytic or equivalent metals as catalysts, which may cause metal ions to remain in the product; some technologies use azides or equivalent oxidants, which may cause explosion hazards during production; most technologies require an anhydrous and oxygen-free environment during operation, resulting in complex operation procedures and high costs, which limits their application in actual production. Therefore, it is of great significance to develop a method for synthesizing amino acid-substituted N-sulfonyl amidine derivatives that does not require metal catalysis, has mild reaction conditions, and is simple to operate. Summary of the invention
[0006] In order to solve the problems of complex operation, harsh reaction conditions and high safety risks in the existing synthesis process of N-sulfonyl amidine compounds, the present invention provides a method for synthesizing amino acid substituted N-sulfonyl amidine derivatives, which can efficiently synthesize various amino acid substituted N-sulfonyl amidine derivatives in the absence of metals and oxidants, avoiding the possibility of metal pollution and explosion, and the method is simple to operate, mild reaction conditions, and stable and easy to control process.
[0007] The present invention is achieved through the following technical solutions:
[0008] The present invention provides a method for synthesizing an amino acid-substituted N-sulfonyl amidine derivative, the method comprising:
[0009] dissolving the amino acid substituted sulfonamide, ethyl bromodifluoroacetate and triethylamine in an organic solvent to obtain a reaction solution;
[0010] Reacting the reaction solution at 60±3° C. for 6±0.5 h to obtain a mixed solution;
[0011] The mixed solution is concentrated and purified to obtain an amino acid substituted N-sulfonyl amidine derivative;
[0012] Wherein, the molar ratio of the amino acid substituted sulfonamide, the ethyl bromodifluoroacetate and the triethylamine is 1:4:4.
[0013] Furthermore, the amino acid substituted sulfonamide, ethyl bromodifluoroacetate and triethylamine are dissolved in an organic solvent to obtain a reaction solution, which specifically includes:
[0014] dissolving amino acid substituted sulfonamide, ethyl bromodifluoroacetate and triethylamine in acetone to obtain a reaction solution;
[0015] Wherein, the molar concentration of the amino acid substituted sulfonamide in the reaction solution is 0.1 mol / L.
[0016] Furthermore, the amino acid substituted sulfonamide, ethyl bromodifluoroacetate and triethylamine are dissolved in acetone to obtain a reaction solution, which specifically includes:
[0017] The amino acid substituted sulfonamide is dissolved in acetone to obtain an amino acid substituted sulfonamide solution, and then ethyl bromodifluoroacetate and triethylamine are added to the amino acid substituted sulfonamide solution, and the mixture is stirred and dissolved to obtain a reaction solution.
[0018] Furthermore, the amino acid in the amino acid substituted sulfonamide includes any one of L-phenylglycine, L-valine, L-leucine, L-glutamic acid, L-phenylalanine, L-homophenylalanine, L-tyrosine, L-tryptophan, L-proline and homoallylglycine.
[0019] Furthermore, the mixed solution is concentrated and purified to obtain the amino acid substituted N-sulfonyl amidine derivative, specifically comprising:
[0020] Concentrating the mixed solution under reduced pressure;
[0021] The residue after concentration under reduced pressure was purified by silica gel flash column chromatography to obtain the amino acid substituted N-sulfonylamidine derivative.
[0022] Furthermore, the silica gel flash column chromatography uses petroleum ether / ethyl acetate as eluent.
[0023] Based on the same inventive concept, the present invention provides an amino acid substituted N-sulfonyl amidine derivative, which is synthesized by the above-mentioned method for synthesizing an amino acid substituted N-sulfonyl amidine derivative.
[0024] Alternatively, the amino acid substituted N-sulfonyl amidine derivative, wherein the amino acid substituted N-sulfonyl amidine derivative includes any one of Formula 1 to Formula 10:
[0025]
[0026] One or more technical solutions in the embodiments of the present invention have at least the following technical effects or advantages:
[0027] 1. The present invention discloses a method for synthesizing amino acid substituted N-sulfonyl amidine derivatives. The method can efficiently synthesize various amino acid substituted N-sulfonyl amidine derivatives in the absence of metals and oxidants, thereby avoiding metal pollution and the possibility of explosion. The process is stable, easy to control, safe and environmentally friendly. In addition, the synthesis method of the present invention has mild reaction conditions, does not require anhydrous and oxygen-free treatment, and avoids cumbersome operations.
[0028] 2. The present invention discloses a method for synthesizing amino acid substituted N-sulfonyl amidine derivatives. The method uses acetone as a solvent and can be quickly recovered and reused after the reaction is completed, thereby reducing production costs and protecting the environment. In addition, the reaction raw materials used in the method are simple and easy to obtain, the substrate has a wide range of application, high atom economy, and high yield. The present invention uses ethyl bromodifluoroacetate as a novel single-carbon source to provide a cheap alternative for synthesizing amino acid substituted N-sulfonyl amidine derivatives. The method also provides a solution for the later modification of natural amino acids, sulfonamides and tertiary amines, and has important academic significance and industrial value. BRIEF DESCRIPTION OF THE DRAWINGS
[0029] In order to more clearly illustrate the technical solutions in the embodiments of the present invention, the following briefly introduces the drawings required for use in the description of the embodiments. Obviously, the drawings described below are some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without creative work.
[0030] Figure 1 The figure is a synthetic route of the amino acid substituted N-sulfonyl amidine derivatives of the present invention. DETAILED DESCRIPTION
[0031] The present invention will be described in detail below in conjunction with specific implementations and examples, and the advantages and various effects of the present invention will be more clearly presented. It should be understood by those skilled in the art that these specific implementations and examples are used to illustrate the present invention, rather than to limit the present invention.
[0032] Throughout the specification, unless otherwise specifically stated, the terms used herein should be understood as meanings commonly used in the art. Therefore, unless otherwise defined, all technical and scientific terms used herein have the same meanings as those generally understood by those skilled in the art to which the present invention belongs. In the event of a conflict, the present specification takes precedence.
[0033] Unless otherwise specified, various raw materials, reagents, instruments and equipment used in the present invention can be purchased from the market or prepared by existing methods.
[0034] The technical principle of the present invention is as follows:
[0035] The present invention provides a method for synthesizing an amino acid substituted N-sulfonyl amidine derivative, the method comprising:
[0036] S1. dissolving the amino acid substituted sulfonamide, ethyl bromodifluoroacetate and triethylamine in an organic solvent to obtain a reaction solution;
[0037] S2. reacting the reaction solution at 60±3° C. for 6±0.5 h to obtain a mixed solution;
[0038] S3. The mixture is concentrated and purified to obtain an amino acid substituted N-sulfonyl amidine derivative;
[0039] Wherein, the molar ratio of the amino acid substituted sulfonamide, the ethyl bromodifluoroacetate and the triethylamine is 1:4:4.
[0040] In the present invention, the role of triethylamine in the reaction solution is to provide N,N-diethyl groups and an alkaline reaction environment for the synthesis of N-sulfonyl amidine derivatives.
[0041] In the present invention, the optimal molar ratio of amino acid substituted sulfonamide, ethyl bromodifluoroacetate and triethylamine is 1:4:4.
[0042] In the present invention, the optimal reaction temperature and reaction time are that the reaction solution is reacted at 60±3°C for 6±0.5h. A reaction temperature lower than or higher than 60±3°C is likely to lead to adverse effects such as incomplete reaction, low reaction efficiency, and increased by-products.
[0043] Step S1 specifically includes:
[0044] dissolving the amino acid substituted sulfonamide in acetone to obtain an amino acid substituted sulfonamide solution, then adding ethyl bromodifluoroacetate and triethylamine to the amino acid substituted sulfonamide solution, stirring and dissolving the mixture sufficiently to obtain a reaction solution;
[0045] Wherein, the molar concentration of the amino acid substituted sulfonamide in the reaction solution is 0.1 mol / L.
[0046] In the present invention, the optimal molar concentration of the amino acid substituted sulfonamide in the reaction solution is 0.1 mol / L.
[0047] Optionally, the amino acid in the amino acid substituted sulfonamide includes any one of L-phenylglycine, L-valine, L-leucine, L-glutamic acid, L-phenylalanine, L-homophenylalanine, L-tyrosine, L-tryptophan, L-proline and homoallylglycine.
[0048] Step S3 specifically includes:
[0049] Concentrating the mixed solution under reduced pressure;
[0050] The residue after concentration under reduced pressure was purified by silica gel flash column chromatography to obtain the amino acid substituted N-sulfonylamidine derivative.
[0051] Optionally, the silica gel flash column chromatography uses petroleum ether / ethyl acetate as eluent.
[0052] In the present invention, the silica gel flash column chromatography method uses petroleum ether / ethyl acetate as an eluent, which has the advantage of being able to quickly separate the product; at the same time, the eluent is recycled and reused, thereby reducing pollution to the environment.
[0053] The following is a detailed description of the synthesis method of an amino acid substituted N-sulfonyl amidine derivative of the present application in combination with examples and experimental data.
[0054] Example 1
[0055] This embodiment provides a method for synthesizing an amino acid substituted N-sulfonyl amidine derivative (Formula 1), such as Figure 1 As shown, specifically including:
[0056]
[0057] At room temperature, L-phenylglycine methyl ester sulfonamide (0.2 mmol, 48.8 mg, 1.0 equiv) was weighed in a 10 ml reaction tube equipped with a magnetic stirrer, and 2 ml of acetone was injected into the reaction tube with a syringe, followed by the addition of ethyl bromodifluoroacetate (0.8 mmol, 102.5 μL, 4.0 equiv) and triethylamine (0.8 mmol, 111.2 μL, 4.0 equiv) with a microsyringe. After the addition of the materials, a rubber stopper was covered and sealed with medical tape, and then the reaction tube was heated in an oil bath at 60°C for 6 hours. After the reaction was completed, the reactant was concentrated under reduced pressure, and the residue was purified by silica gel flash column chromatography using petroleum ether / ethyl acetate (1:1) as the eluent to obtain a white solid product (62.8 mg, 96%).
[0058] 1 H NMR (400 MHz, CDCl 3 )δ7.86(s,1H),7.45–7.21(m,5H),5.50(d,J=7.9Hz,1H),5.12(d,J=7.9Hz,1H),3.7 1(s,3H),3.26(dq,J=14.5,7.3Hz,4H),1.18(t,J=7.2Hz,3H),1.06(t,J=7.2Hz,3H). 13 C NMR (101 MHz, CDCl 3 )δ171.3,158.0,136.2,128.6,128.3,127.3,59.6,52.8,46.7,40.5,14.3,11.8.HRMS(ESI-TOF)m / z:[M+H] + ca lcd for C 14 H 22 N 3 O4 S, 328.1331; found, 328.1329.
[0059] Example 2
[0060] This embodiment provides a method for synthesizing an amino acid substituted N-sulfonyl amidine derivative (Formula 2), which specifically comprises:
[0061]
[0062] At room temperature, L-valine ethyl ester sulfonamide (0.2mmol, 44.8mg, 1.0eq iv) was weighed in a 10ml reaction tube equipped with a magnetic stirrer, 2ml acetone was injected into the reaction tube with a syringe, and then ethyl bromodifluoroacetate (0.8mmo l, 102.5μL, 4.0eq iv) and triethylamine (0.8mmo l, 111.2μL, 4.0eq iv) were added with a micro syringe. After the addition of the materials, a rubber stopper was covered and sealed with medical tape, and then the reaction tube was heated in an oil bath at 60℃ for 6 hours. After the reaction was completed, the reactant was concentrated under reduced pressure, and the residue was purified by silica gel flash column chromatography, using petroleum ether / ethyl acetate (1:1) as the eluent to obtain a colorless oil product (54.0mg, 88%).
[0063] 1 H NMR (400 MHz, CDCl 3 )δ7.95(s,1H),4.84(d,J=9.8Hz,1H),4.21–4.03(m,2H),3.70(dd,J=9.7,4.9Hz,1H),3.43–3.23(m,4H),2.00(td,J =13.1,6.6Hz,1H),1.21(dd,J=16.7,7.2Hz,6H),1.09(t,J=7.2Hz,3H),0.95(d,J=6.8Hz,3H),0.84(d,J=6.8Hz,3H). 13 C NMR (101 MHz, CDCl 3 )δ172.3,157.9,61.1,46.7,40.4,31.5,18.9,17.3,14.3,14.1,11.7.HRMS(ESI-TOF)m / z:[M+H] + ca lcd for C 12 H 26 N 3 O 4 S, 308.1644; found, 308.1646.
[0064] Example 3
[0065] This embodiment provides a method for synthesizing an amino acid substituted N-sulfonyl amidine derivative (Formula 3), which specifically includes:
[0066]
[0067] At room temperature, L-leucine methyl ester sulfonamide (0.2mmol, 44.8mg, 1.0eq iv) was weighed in a 10ml reaction tube equipped with a magnetic stirrer, 2ml acetone was injected into the reaction tube with a syringe, and then ethyl bromodifluoroacetate (0.8mmo l, 102.5μL, 4.0eq iv) and triethylamine (0.8mmo l, 111.2μL, 4.0eq iv) were added with a micro syringe. After the addition of the materials, a rubber stopper was covered and sealed with medical tape, and then the reaction tube was heated in an oil bath at 60℃ for 6 hours. After the reaction was completed, the reactant was concentrated under reduced pressure, and the residue was purified by silica gel flash column chromatography, using petroleum ether / ethyl acetate (2:1) as the eluent to obtain a colorless oil product (46.1mg, 75%).
[0068] 1 H NMR (400 MHz, CDCl 3 )δ7.98(s,1H),4.78(d,J=10.0Hz,1H),3.95(td,J=9.3,6.1Hz,1H),3.69(s,3H),3.43–3.28(m,4H),1.83(dt,J =13.5,6.7Hz,1H),1.51–1.42(m,2H),1.23(t,J=7.2Hz,3H),1.13(t,J=7.2Hz,3H),0.91(dd,J=9.2,6.9Hz,6H). 13 C NMR (101 MHz, CDCl 3 )δ174.0,158.1,54.6,52.1,46.7,42.4,40.4,24.3,22.7,21.5,14.4,11.8.HRMS(ESI-TOF)m / z:[M+H] + ca lcd for C 12 H 26 N 3 O 4 S, 308.1644; found, 308.1638.
[0069] Example 4
[0070] This embodiment provides a method for synthesizing an amino acid substituted N-sulfonyl amidine derivative (Formula 4), which specifically comprises:
[0071]
[0072] At room temperature, L-glutamic acid diethyl ester sulfonamide (0.2 mmol, 56.4 mg, 1.0 equiv) was weighed in a 10 ml reaction tube equipped with a magnetic stirrer, and 2 ml of acetone was injected into the reaction tube with a syringe, followed by the addition of ethyl bromodifluoroacetate (0.8 mmol, 102.5 μL, 4.0 equiv) and triethylamine (0.8 mmol, 111.2 μL, 4.0 equiv) with a microsyringe. After the addition of the materials, the rubber stopper was covered and sealed with medical tape, and then the reaction tube was heated in an oil bath at 60°C for 6 hours. After the reaction was completed, the reactant was concentrated under reduced pressure, and the residue was purified by silica gel flash column chromatography using petroleum ether / ethyl acetate (2:1) as the eluent to obtain a yellow oil product (67.9 mg, 93%).
[0073] 1 H NMR (400 MHz, CDCl 3 )δ7.95(s,1H),4.95(d,J=8.8Hz,1H),4.11(dq,J=28.2,7.0Hz,4H),3.94(dd,J=13.3,8.7Hz,1H),3.39–3.2 7(m,4H),2.50–2.40(m,2H),2.13–2.04(m,1H),1.89–1.79(m,1H),1.26–1.16(m,9H),1.09(t,J=7.2Hz,3H). 13 C NMR (101 MHz, CDCl 3 )δ172.6,172.3,158.0,61.5,60.3,55.2,46.8,40.5,29.8,28.3,14.3,14.03,13.98,11.7.HRMS(ESI-TOF)m / z:[M+H] + ca lcd for C 14 H 28 N 3 O 6 S,366.1699; found,366.1698.
[0074] Example 5
[0075] This embodiment provides a method for synthesizing an amino acid substituted N-sulfonyl amidine derivative (Formula 5), which specifically comprises:
[0076]
[0077] At room temperature, L-phenylalanine methyl ester sulfonamide (0.2 mmol, 51.6 mg, 1.0 equiv) was weighed in a 10 ml reaction tube equipped with a magnetic stirrer, and 2 ml of acetone was injected into the reaction tube with a syringe, followed by the addition of ethyl bromodifluoroacetate (0.8 mmol, 102.5 μL, 4.0 equiv) and triethylamine (0.8 mmol, 111.2 μL, 4.0 equiv) with a microsyringe. After the addition of the materials, a rubber stopper was covered and sealed with medical tape, and then the reaction tube was heated in an oil bath at 60°C for 6 hours. After the reaction was completed, the reactant was concentrated under reduced pressure, and the residue was purified by silica gel flash column chromatography using petroleum ether / ethyl acetate (2:1) as the eluent to obtain a colorless oil product (58.0 mg, 85%).
[0078] 1 H NMR (400 MHz, CDCl 3 )δ7.95(s,1H),7.31–7.13(m,5H),4.85(d,J=9.0Hz,1H),4.29(dd,J=15.0,6.1Hz,1H),3.65(s,3H) ,3.35(dq,J=22.0,7.1Hz,4H),3.08(d,J=6.0Hz,2H),1.23(t,J=7.2Hz,3H),1.12(t,J=7.1Hz,3H). 13 C NMR (101 MHz, CDCl 3 )δ172.2,158.0,135.5,129.4,128.4,127.0,57.0,52.1,46.8,40.5,39.3,14.3,11.8.HRMS(ESI-TOF)m / z:[M+H] + ca lcd for C 15 H 24 N 3 O 4 S,342.1488; found,342.1483.
[0079] Example 6
[0080] This embodiment provides a method for synthesizing an amino acid substituted N-sulfonyl amidine derivative (Formula 6), which specifically includes:
[0081]
[0082] At room temperature, L-homophenylalanine ethyl ester sulfonamide (0.2 mmol, 57.2 mg, 1.0 equiv) was weighed in a 10 ml reaction tube equipped with a magnetic stirrer, and 2 ml of acetone was injected into the reaction tube with a syringe, followed by the addition of ethyl bromodifluoroacetate (0.8 mmol, 102.5 μL, 4.0 equiv) and triethylamine (0.8 mmol, 111.2 μL, 4.0 equiv) with a microsyringe. After the addition of the materials, the rubber stopper was covered and sealed with medical tape, and then the reaction tube was heated in an oil bath at 60°C for 6 hours. After the reaction was completed, the reactant was concentrated under reduced pressure, and the residue was purified by silica gel flash column chromatography using petroleum ether / ethyl acetate (2:1) as the eluent to obtain a colorless oil product (69.4 mg, 94%).
[0083] 1 H NMR (400 MHz, CDCl 3 )δ8.02(s,1H),7.27(t,J=7.3Hz,2H),7.20(d,J=7.4Hz,3H),5.04(d,J=8.9Hz,1H),4.22–4.08(m,2H),4.00(dd,J=13.4,8.2Hz,1H), 3.44–3.30(m,4H),2.76(t,J=7.4Hz,2H),2.14–2.05(m,1H),1.99–1.89(m,1H),1.25(dd,J=16.3,7.4Hz,6H),1.13(t,J=7.2Hz,3H). 13 C NMR (101 MHz, CDCl 3 )δ172.6,158.0,140.8,128.4,128.3,125.9,61.4,55.7,46.7,40.5,35.1,31.3,14.3,14.1,11.8.HRMS(ESI-TOF)m / z:[M+H] + ca lcd for C 17 H 28 N 3 O 4 S, 370.1801; found, 370.1801.
[0084] Example 7
[0085] This embodiment provides a method for synthesizing an amino acid substituted N-sulfonyl amidine derivative (Formula 7), which specifically comprises:
[0086]
[0087] At room temperature, L-tyrosine methyl ester sulfonamide (0.2mmol, 54.8mg, 1.0eq iv) was weighed in a 10ml reaction tube equipped with a magnetic stirrer, 2ml acetone was injected into the reaction tube with a syringe, and then ethyl bromodifluoroacetate (0.8mmo l, 102.5μL, 4.0eq iv) and triethylamine (0.8mmo l, 111.2μL, 4.0eq iv) were added with a micro syringe. After the addition of the materials, a rubber stopper was covered and sealed with medical tape, and then the reaction tube was heated in an oil bath at 60℃ for 6 hours. After the reaction was completed, the reactant was concentrated under reduced pressure, and the residue was purified by silica gel flash column chromatography, using petroleum ether / ethyl acetate (1:2) as the eluent to obtain a colorless oil product (40.0mg, 56%).
[0088] 1 H NMR (400 MHz, CDCl 3 )δ7.91(s,1H),6.98(d,J=7.8Hz,2H),6.71(d,J=7.8Hz,2H),6.46(s,1H),4.91(d,J=9.0Hz,1H),4.21(d,J=7. 0Hz,1H),3.65(s,3H),3.39–3.25(m,4H),2.99(d,J=18.1Hz,2H),1.19(t,J=6.9Hz,3H),1.09(t,J=6.9Hz,3H). 13 C NMR (101 MHz, CDCl 3 )δ172.6,158.1,155.3,130.4,126.8,115.4,57.2,52.2,46.9,40.6,38.4,14.3,11.8.HRMS(ESI-TOF)m / z:[M+H] + ca lcd for C 15 H 24 N 3 O 5 S,358.1437; found,358.1436.
[0089] Example 8
[0090] This embodiment provides a method for synthesizing an amino acid substituted N-sulfonyl amidine derivative (Formula 8), which specifically includes:
[0091]
[0092] At room temperature, L-tryptophan ethyl ester sulfonamide (0.2mmol, 62.2mg, 1.0eq iv) was weighed in a 10ml reaction tube equipped with a magnetic stirrer, 2ml acetone was injected into the reaction tube with a syringe, and then ethyl bromodifluoroacetate (0.8mmo l, 102.5μL, 4.0eq iv) and triethylamine (0.8mmo l, 111.2μL, 4.0eq iv) were added with a micro syringe. After the addition of the materials, a rubber stopper was covered and sealed with medical tape, and then the reaction tube was heated in an oil bath at 60℃ for 6 hours. After the reaction was completed, the reactant was concentrated under reduced pressure, and the residue was purified by silica gel flash column chromatography, using petroleum ether / ethyl acetate (1:1) as the eluent to obtain a colorless oil product (68.6mg, 87%).
[0093] 1 H NMR (400 MHz, CDCl 3 )δ8.50(s,1H),7.91(s,1H),7.56(d,J=7.8Hz,1H),7.33(d,J=8.0Hz,1H) ,7.13(t,J=7.4Hz,1H),7.05(d,J=9.9Hz,2H),4.99(d,J=8.6Hz,1H),4.3 0(dd,J=13.7,6.0Hz,1H),4.04(q,J=7.0Hz,2H),3.26(t,J=7.4Hz,4H),3.19(q,J=7.1Hz,2H),1.13(dd,J=17.4,7.4Hz,6H),1.04(t,J=7.1Hz,3H). 13 C NMR (101 MHz, CDCl 3 )δ172.2,158.0,136.0,127.3,123.5,121.7,119.2,118.4,111.3,109.2, 61.3,56.5,46.7,40.4,29.1,14.2,13.8,11.7.HRMS(ESI-TOF)m / z:[M+H] + ca lcd for C 18 H 27 N 4 O 4 S, 395.1753; found, 395.1750.
[0094] Example 9
[0095] This embodiment provides a method for synthesizing an amino acid substituted N-sulfonyl amidine derivative (Formula 9), which specifically comprises:
[0096]
[0097] At room temperature, L-proline tert-butyl ester sulfonamide (0.2 mmol, 50.0 mg, 1.0 equiv) was weighed in a 10 ml reaction tube equipped with a magnetic stirrer, and 2 ml of acetone was injected into the reaction tube with a syringe, followed by the addition of ethyl bromodifluoroacetate (0.8 mmol, 102.5 μL, 4.0 equiv) and triethylamine (0.8 mmol, 111.2 μL, 4.0 equiv) with a microsyringe. After the addition of the materials, a rubber stopper was covered and sealed with medical tape, and then the reaction tube was heated in an oil bath at 60°C for 6 hours. After the reaction was completed, the reactant was concentrated under reduced pressure, and the residue was purified by silica gel flash column chromatography using petroleum ether / ethyl acetate (2:1) as the eluent to obtain a colorless oil product (57.3 mg, 86%).
[0098] 1 H NMR (400 MHz, CDCl 3 )δ8.03(s,1H),4.07(d,J=8.6Hz,1H),3.49–3.37(m,3H),3.36–3.26(m,3H),2.10(d,J=6 .9Hz,1H),2.02–1.70(m,4H),1.42(s,9H),1.22(t,J=7.1Hz,3H),1.14(t,J=7.1Hz,3H). 13 C NMR (101 MHz, CDCl 3 )δ171.8,158.5,81.0,61.6,49.2,46.8,40.5,31.0,27.8,24.7,14.3,11.9.HRMS(ESI-TOF)m / z:[M+H] + ca lcd forC 14 H 28 N 3 O 4 S, 334.1801; found, 334.1798.
[0099] Example 10
[0100] This embodiment provides a method for synthesizing an amino acid substituted N-sulfonyl amidine derivative (Formula 10), which specifically comprises:
[0101]
[0102] At room temperature, homoallylglycine ethyl ester sulfonamide (0.2 mmol, 44.4 mg, 1.0 equiv) was weighed in a 10 ml reaction tube equipped with a magnetic stirrer, and 2 ml of acetone was injected into the reaction tube with a syringe, followed by the addition of ethyl bromodifluoroacetate (0.8 mmol, 102.5 μL, 4.0 equiv) and triethylamine (0.8 mmol, 111.2 μL, 4.0 equiv) with a microsyringe. After the addition of the materials, the rubber stopper was covered and sealed with medical tape, and then the reaction tube was heated in an oil bath at 60°C for 6 hours. After the reaction was completed, the reactant was concentrated under reduced pressure, and the residue was purified by silica gel flash column chromatography using petroleum ether / ethyl acetate (2:1) as the eluent to obtain a yellow solid product (59.2 mg, 97%).
[0103] 1 H NMR (400 MHz, CDCl 3 )δ7.97(s,1H),5.70(td,J=17.1,7.2Hz,1H),5.07(dd,J=13.0,8.0Hz,2H),4.94(d,J=8.7Hz,1H),4.13(ddd,J=17.6,10.6,3.6Hz,2H),4 .01(dd,J=14.4,6.1Hz,1H),3.34(ddd,J=22.0,10.6,6.2Hz,4H),2.55–2.40(m,2H),1.21(dd,J=13.1,6.9Hz,6H),1.10(t,J=7.2Hz,3H). 13 C NMR (101 MHz, CDCl 3 )δ171.8,158.0,131.9,118.8,61.3,55.5,46.7,40.4,37.5,14.3,14.1,11.7.HRMS(ESI-TOF)m / z:[M+Na] + ca lcdfor C 12 H 23 N 3 O 4 SNa,328.1307; found,328.1312.
[0104] Finally, it should be noted that the terms "comprises," "includes," or any other variations thereof are intended to cover non-exclusive inclusion, such that a process, method, article, or apparatus that includes a series of elements includes not only those elements, but also other elements not explicitly listed, or also includes elements that are inherent to such process, method, article, or apparatus.
[0105] Although the preferred embodiments of the present invention have been described, those skilled in the art may make other changes and modifications to these embodiments once they have learned the basic creative concept. Therefore, the appended claims are intended to be interpreted as including the preferred embodiments and all changes and modifications that fall within the scope of the present invention.
[0106] Obviously, those skilled in the art can make various changes and modifications to the present invention without departing from the spirit and scope of the present invention. Thus, if these modifications and variations of the present invention fall within the scope of the claims of the present invention and their equivalents, the present invention is also intended to include these modifications and variations.
Claims
1. A method for synthesizing an amino acid substituted N-sulfonyl amidine derivative, characterized in that: The synthesis method comprises: dissolving the amino acid substituted sulfonamide, ethyl bromodifluoroacetate and triethylamine in an organic solvent to obtain a reaction solution; Reacting the reaction solution at 60±3° C. for 6±0.5 h to obtain a mixed solution; The mixed solution is concentrated and purified to obtain an amino acid substituted N-sulfonyl amidine derivative; Wherein, the molar ratio of the amino acid substituted sulfonamide, the ethyl bromodifluoroacetate and the triethylamine is 1:4:
4.
2. The method for synthesizing an amino acid substituted N-sulfonyl amidine derivative according to claim 1, characterized in that: The step of dissolving the amino acid substituted sulfonamide, ethyl bromodifluoroacetate and triethylamine in an organic solvent to obtain a reaction solution specifically comprises: dissolving amino acid substituted sulfonamide, ethyl bromodifluoroacetate and triethylamine in acetone to obtain a reaction solution; Wherein, the molar concentration of the amino acid substituted sulfonamide in the reaction solution is 0.1 mol / L.
3. The method for synthesizing an amino acid substituted N-sulfonyl amidine derivative according to claim 2, characterized in that: The step of dissolving the amino acid substituted sulfonamide, ethyl bromodifluoroacetate and triethylamine in acetone to obtain a reaction solution specifically comprises: The amino acid substituted sulfonamide is dissolved in acetone to obtain an amino acid substituted sulfonamide solution, and then ethyl bromodifluoroacetate and triethylamine are added to the amino acid substituted sulfonamide solution, and the mixture is stirred and dissolved to obtain a reaction solution.
4. The method for synthesizing an amino acid substituted N-sulfonyl amidine derivative according to claim 1 or 2, characterized in that: The amino acid in the amino acid substituted sulfonamide includes any one of L-phenylglycine, L-valine, L-leucine, L-glutamic acid, L-phenylalanine, L-homophenylalanine, L-tyrosine, L-tryptophan, L-proline and homoallylglycine.
5. The method for synthesizing an amino acid substituted N-sulfonyl amidine derivative according to claim 1, characterized in that: The mixed solution is concentrated and purified to obtain an amino acid substituted N-sulfonyl amidine derivative, which specifically comprises: Concentrating the mixed solution under reduced pressure; The residue after concentration under reduced pressure was purified by silica gel flash column chromatography to obtain the amino acid substituted N-sulfonylamidine derivative.
6. The method for synthesizing an amino acid substituted N-sulfonyl amidine derivative according to claim 5, characterized in that: The silica gel flash column chromatography uses petroleum ether / ethyl acetate as eluent.
7. An amino acid substituted N-sulfonyl amidine derivative, characterized in that: The amino acid substituted N-sulfonyl amidine derivative is synthesized by the method for synthesizing an amino acid substituted N-sulfonyl amidine derivative according to any one of claims 1-6.
8. An amino acid substituted N-sulfonyl amidine derivative, characterized in that: The amino acid substituted N-sulfonyl amidine derivatives include any one of Formula 1 to Formula 10:
